PGC-1α-mediated regulation of mitochondrial function and physiological implications

The majority of human energy metabolism occurs in skeletal muscle mitochondria emphasizing the importance of understanding the regulation of myocellular mitochondrial function. The transcriptional co-activator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) has been characterized as a major factor in the transcriptional control of several mitochondrial components. Thus, PGC-1α is often described as a master regulator of mitochondrial biogenesis as well as a central player in regulating the antioxidant defense. However, accumulating evidence suggests that PGC-1α is also involved in the complex regulation of mitochondrial quality beyond biogenesis, which includes mitochondrial network dynamics and autophagic removal of damaged mitochondria. In addition, mitochondrial reactive oxygen species production has been suggested to regulate skeletal muscle insulin sensitivity, which may also be influenced by PGC-1α. This review aims to highlight the current evidence for PGC-1α-mediated regulation of skeletal muscle mitochondrial function beyond the effects on mitochondrial biogenesis as well as the potential PGC-1α-related impact on insulin-stimulated glucose uptake in skeletal muscle. Novelty PGC-1α regulates mitochondrial biogenesis but also has effects on mitochondrial functions beyond biogenesis. Mitochondrial quality control mechanisms, including fission, fusion, and mitophagy, are regulated by PGC-1α. PGC-1α-mediated regulation of mitochondrial quality may affect age-related mitochondrial dysfunction and insulin sensitivity.

Age-, sex-, and region-specific differences in skeletal muscle size and quality

Ultrasonography-derived cross-sectional area (CSA) and echo intensity (EI) are increasingly utilized by investigators to study muscle size and quality, respectively. We sought to examine age, sex, and region (proximal, middle, distal) differences in vastus lateralis and rectus femoris CSA and EI, and determine whether correction for subcutaneous fat thickness influences the magnitude of EI differences. Fifteen younger men (mean age = 23 years), 15 younger women (aged 21 years), 11 older men (aged 74 years), and 15 older women (aged 70 years) participated. Clear differences were observed among age, sex, and region for vastus lateralis CSA (p ≤ 0.013, d = 0.38-0.73), whereas rectus femoris CSA was only different between younger and older participants at the proximal region (p = 0.017, d = 0.65). Uncorrected EI was greatest at the distal region of both muscles (p < 0.001, d = 0.59-1.38), with only the younger men having significantly lower EI values than the other groups (p ≤ 0.043, d = 0.37-0.63). Subcutaneous fat correction resulted in a marked increase in the magnitude of sex-specific EI differences (p ≤ 0.032, d ≥ 0.42). Additionally, subcutaneous fat correction increased the uniformity of EI throughout the thigh. These findings highlight considerable region-specific differences in muscle size and quality among younger and older men and women and highlight the need to correct for subcutaneous fat thickness when examining EI. Novelty Rectus femoris CSA is similar between younger and older adults except at the most proximal site evaluated. Age- and sex-specific differences in uncorrected EI are nonuniform across the thigh. Correction for subcutaneous fat thickness substantially increased EI in women, resulting in greater sex differences.

Variability of regional quadriceps echo intensity in active young men with and without subcutaneous fat correction

Quantifying echo intensity (EI), a proposed measure of muscle quality, is becoming increasingly popular. Additionally, much attention has been paid to regional differences in other ultrasonically evaluated measures of muscle morphology and architecture. However, the variability of regional (proximal, middle, distal) EI of the vastus lateralis, rectus femoris, and lateral and anterior vastus intermedius has yet to be determined. Twenty participants (40 limbs), were evaluated on 3 occasions, separated by 7 days. Intersession variability of EI with and without subcutaneous fat correction was quantified. Furthermore, the interchangeability of corrected EI across regions was evaluated. Variability of regional quadriceps EI was substantially lower with subcutaneous fat correction (intraclass correlation coefficient (ICC) = 0.81-0.98, coefficient of variation (CV) = 4.5%-16.8%, typical error of measure (TEM) = 0.13-0.49) versus raw values (ICC = 0.69-0.98, CV = 7.7%-42.7%, TEM = 0.14-0.68), especially when examining the vastus intermedius (ICC = 0.81-0.95, CV = 7.1%-16.8%, TEM = 0.23-0.49 vs. ICC = 0.69-0.92, CV = 22.9%-42.7%, TEM = 0.31-0.68). With the exception of the rectus femoris and vastus intermedius (p ≥ 0.143, effect size (ES) ≤ 0.18), corrected EI was greater for proximal and distal regions when compared with the midpoint (p ≤ 0.038, ES = 0.38-0.82). Researchers and practitioners should utilize subcutaneous fat thickness correction to confidently evaluate EI at all regions of the quadriceps. Regional EI cannot be used interchangeably for the vastus muscles, likely because of an increase in fibrous content towards the myotendinous junctions. Novelty Regional quadriceps echo intensity was reliable with and without correction for subcutaneous fat thickness. Intersession variability of regional quadriceps echo intensity was substantially improved following subcutaneous fat correction. Quadriceps echo intensity increased towards myotendinous junctions in the vastus muscles.

The sarcoplasmic reticulum and SERCA: a nexus for muscular adaptive thermogenesis

We are currently facing an "obesity epidemic" worldwide. Promoting inefficient metabolism in muscle represents a potential treatment for obesity and its complications. Sarco(endo)plasmic reticulum (SR) Ca²⁺-ATPase (SERCA) pumps in muscle are responsible for maintaining low cytosolic Ca²⁺ concentration through the ATP-dependent pumping of Ca²⁺ from the cytosol into the SR lumen. SERCA activity has the potential to be a critical regulator of body mass and adiposity given that it is estimated to contribute upwards of 20% of daily energy expenditure. More interestingly, this fraction can be modified physiologically in the face of stressors, such as ambient temperature and diet, through its physical interaction with several regulators known to inhibit Ca²⁺ uptake and muscle function. In this review, we discuss advances in our understanding of Ca²⁺-cycling thermogenesis within skeletal muscle, focusing on SERCA and its protein regulators, which were thought previously to only modulate muscular contractility. Novelty ATP consumption by SERCA pumps comprises a large proportion of resting energy expenditure in muscle and is dynamically regulated through interactions with small SERCA regulatory proteins. SERCA efficiency correlates significantly with resting metabolism, such that individuals with a higher resting metabolic rate have less energetically efficient SERCA Ca²⁺ pumping in muscle (i.e., lower coupling ratio). Futile Ca²⁺ cycling is a versatile heat generating mechanism utilized by both skeletal muscle and beige fat.

Sodium 4-phenylbutyrate reduces myofiber damage in a mouse model of Duchenne muscular dystrophy

We performed a placebo-controlled pre-clinical study to determine if sodium 4-phenylbutyrate (4PB) can reduce contraction-induced myofiber damage in the mdx mouse model of Duchenne muscular dystrophy (DMD). At 72 h post-eccentric contractions, 4PB significantly increased contractile torque and reduced myofiber damage and macrophage infiltration. We conclude that 4PB, which is approved by Health Canada (Pheburane) and the United States Food and Drug Administration (Buphenyl) for urea cycle disorders, might modify disease severity in patients with DMD.